Clinical Trials in Los Angeles

Showing 8361-8380 of 12,794 trials

Musculoskeletal Ultrasound Assessment of Therapeutic Response of Tofacitinib in Rheumatoid Arthritis Patients

NCT02321930

This proposal will evaluate if musculoskeletal ultrasound (MSUS) measures or multi-biomarker disease activity (MBDA) improve in patients treated with tofacitinib over 3 months, and whether early MSUS measures/MBDA can predict response to therapy.

Rheumatoid Arthritis

University of California, Los Angeles37 participantsStarted Feb 2016

Los Angeles, California, United States

COMPLETEDPhase 3< 1 mile

Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine

NCT02867709

This study will evaluate the efficacy, safety, and tolerability of 2 doses of ubrogepant (25 and 50 mg) compared to placebo for the acute treatment of a single migraine attack.

Migraine, With or Without Aura

Allergan1,686 participantsStarted Aug 2016

Birmingham, Alabama, United States • Chandler, Arizona, United States • Phoenix, Arizona, United States +106 more locations

Musculoskeletal Ultrasound Assessment of Therapeutic Response of Tofacitinib in Rheumatoid Arthritis Patients

Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine

Find Trials by Condition in Los Angeles

Long-term Safety and Tolerability of Atacicept (Long-term Follow-Up of Participant Who Participated in ADDRESS II)

Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination

DF4 Connector System Post-Approval Study

Omadacycline Versus Linezolid for the Treatment of ABSSSI (EudraCT #2013-003644-23)

Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine

An Open-label Study to Evaluate the Long-term Safety and Tolerability of LUM001 in Patients With Primary Biliary Cirrhosis

Early Diagnosis of Candidiasis in Premature Infants

Observational Study of Surgical Treatment of Necrotizing Enterocolotis

A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer

Investigational Device Exemption Study to Determine the Safety and Efficacy of the Astron and Pulsar Stents

Immunogenicity of PCV-7 Vaccine in VLBW Infants

Exosurf Neonatal and Survanta for Treatment of Respiratory Distress Syndrome

Persistent Pulmonary Hypertension of the Newborn (PPHN) Observational Study

Whole-Body Cooling for Birth Asphyxia in Term Infants

Antenatal Phenobarbital to Prevent Neonatal Intracranial Hemorrhage

Phase IIIb Study of APD421 in Combination as PONV Prophylaxis

UltraShape Power for Abdominal Fat and Circumference Reduction

52-104 Week Off-therapy Second Extension to Study CSPP100A2365